Helge Stenvold

1.3k total citations
17 papers, 907 citations indexed

About

Helge Stenvold is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Helge Stenvold has authored 17 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Helge Stenvold's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (5 papers). Helge Stenvold is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (5 papers). Helge Stenvold collaborates with scholars based in Norway, Denmark and Singapore. Helge Stenvold's co-authors include Roy M. Bremnes, Samer Al‐Saad, Lill‐Tove Busund, Tom Dønnem, Sigve Andersen, Khalid Al‐Shibli, Rafael Sirera, Carlos Camps, Thomas Berg and Sveinung Wergeland Sørbye and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Helge Stenvold

17 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helge Stenvold Norway 14 532 503 288 162 161 17 907
Qijia Xuan China 18 325 0.6× 241 0.5× 511 1.8× 223 1.4× 161 1.0× 30 922
Jolanta Pamuła‐Piłat Poland 15 719 1.4× 381 0.8× 297 1.0× 79 0.5× 86 0.5× 30 1.0k
Lidia Rita Corsini Italy 19 430 0.8× 323 0.6× 381 1.3× 69 0.4× 164 1.0× 41 892
Haishan Zhao China 17 527 1.0× 305 0.6× 300 1.0× 62 0.4× 74 0.5× 31 790
Sayuri Akiyoshi Japan 17 707 1.3× 534 1.1× 371 1.3× 60 0.4× 124 0.8× 35 1.0k
Ali E. Yesilkanal United States 8 491 0.9× 205 0.4× 146 0.5× 73 0.5× 76 0.5× 10 733
Koji Yamanoi Japan 12 290 0.5× 228 0.5× 464 1.6× 362 2.2× 134 0.8× 72 946
Prashanth Prithviraj Australia 13 319 0.6× 155 0.3× 405 1.4× 192 1.2× 193 1.2× 28 753
Masaya Kai Japan 15 361 0.7× 177 0.4× 422 1.5× 105 0.6× 83 0.5× 35 698

Countries citing papers authored by Helge Stenvold

Since Specialization
Citations

This map shows the geographic impact of Helge Stenvold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helge Stenvold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helge Stenvold more than expected).

Fields of papers citing papers by Helge Stenvold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helge Stenvold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helge Stenvold. The network helps show where Helge Stenvold may publish in the future.

Co-authorship network of co-authors of Helge Stenvold

This figure shows the co-authorship network connecting the top 25 collaborators of Helge Stenvold. A scholar is included among the top collaborators of Helge Stenvold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helge Stenvold. Helge Stenvold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Brun, Vegard Heimly, et al.. (2021). Severe hypercalcemia caused by parathyroid hormone in a rectal cancer metastasis: a case report. BMC Endocrine Disorders. 21(1). 4–4. 1 indexed citations
2.
Kiselev, Yury, Sigve Andersen, Karina Standahl Olsen, et al.. (2018). Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer. Scientific Reports. 8(1). 5059–5059. 13 indexed citations
3.
Andersen, Sigve, Samer Al‐Saad, Yury Kiselev, et al.. (2014). Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival. PLoS ONE. 9(9). e105038–e105038. 63 indexed citations
4.
Stenvold, Helge, Tom Dønnem, Sigve Andersen, et al.. (2014). High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome. BMC Clinical Pathology. 14(1). 9–9. 22 indexed citations
5.
Stenvold, Helge, Tom Dønnem, Sigve Andersen, et al.. (2014). Stage and tissue-specific prognostic impact of miR-182 in NSCLC. BMC Cancer. 14(1). 138–138. 31 indexed citations
6.
Andersen, Sigve, Samer Al‐Saad, Elin Richardsen, et al.. (2013). Positive prognostic impact of miR-210 in non-small cell lung cancer. Lung Cancer. 83(2). 272–278. 53 indexed citations
7.
Hald, Sigurd M., Roy M. Bremnes, Khalid Al‐Shibli, et al.. (2013). CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy. Lung Cancer. 80(2). 209–215. 44 indexed citations
8.
Andersen, Sigve, Samer Al‐Saad, Yury Kiselev, et al.. (2013). Abstract 2377: MCT1 and MCT4 in NSCLC: Overexpression of MCT1 in tumor and stroma is an independent prognostic marker for NSCLC survival.. Cancer Research. 73(8_Supplement). 2377–2377. 1 indexed citations
9.
Dønnem, Tom, Christopher G. Fenton, Thomas Berg, et al.. (2012). MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer. PLoS ONE. 7(1). e29671–e29671. 91 indexed citations
10.
Andersen, Sigve, Tom Dønnem, Samer Al‐Saad, et al.. (2011). Correlation and coexpression of HIFs and NOTCH markers in NSCLC.. PubMed. 31(5). 1603–6. 14 indexed citations
11.
Dønnem, Tom, Thomas Berg, Sveinung Wergeland Sørbye, et al.. (2011). Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer. Cancer. 117(14). 3193–3200. 62 indexed citations
12.
Dønnem, Tom, Thomas Berg, Sveinung Wergeland Sørbye, et al.. (2011). Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization. Journal of Translational Medicine. 9(1). 6–6. 96 indexed citations
13.
Stenvold, Helge, Tom Dønnem, Sigve Andersen, et al.. (2011). Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: Correlation with a favorable clinical outcome. Lung Cancer. 75(2). 235–241. 23 indexed citations
14.
Andersen, Sigve, Tom Dønnem, Helge Stenvold, et al.. (2011). Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival. PLoS ONE. 6(8). e23847–e23847. 50 indexed citations
15.
Andersen, Sigve, Tom Dønnem, Khalid A. Alshibli, et al.. (2011). Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2. PLoS ONE. 6(5). e19773–e19773. 31 indexed citations
16.
Bremnes, Roy M., Khalid Al‐Shibli, Tom Dønnem, et al.. (2010). The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(4). 824–833. 275 indexed citations
17.
Kampman, Margitta T., et al.. (2005). Management of Women with Epilepsy: Are Guidelines Being Followed? Results from Case‐note Reviews and a Patient Questionnaire. Epilepsia. 46(8). 1286–1292. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qijia Xuan Breakdown of academic impact, for papers by Jolanta Pamuła‐Piłat Breakdown of academic impact, for papers by Lidia Rita Corsini Breakdown of academic impact, for papers by Haishan Zhao Breakdown of academic impact, for papers by Sayuri Akiyoshi Breakdown of academic impact, for papers by Ali E. Yesilkanal Breakdown of academic impact, for papers by Koji Yamanoi Breakdown of academic impact, for papers by Prashanth Prithviraj Breakdown of academic impact, for papers by Masaya Kai
Rankless by CCL
2026